The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of site-specific metastases on survival outcomes in pancreatic adenocarcinoma (PDAC) patients: A national analysis.
 
Nima Nikravesh
No Relationships to Disclose
 
Gillian Gresham
No Relationships to Disclose
 
Eric Anderson
No Relationships to Disclose
 
Omer Elmadbouh
No Relationships to Disclose
 
Shant Thomassian
No Relationships to Disclose
 
Natalie Moshayedi
No Relationships to Disclose
 
John Davelaar
No Relationships to Disclose
 
Simon Lo
No Relationships to Disclose
 
Srinivas Gaddam
No Relationships to Disclose
 
Nicholas Nissen
No Relationships to Disclose
 
Kambiz Kosari
No Relationships to Disclose
 
Alexandra Gangi
No Relationships to Disclose
 
Stephen Jacob Pandol
Leadership - Avenzoar
Stock and Other Ownership Interests - Avenzoar; Lucid Sciences; Phyteau
Consulting or Advisory Role - Empirico; Kezar Life Sciences
Patents, Royalties, Other Intellectual Property - Patents and patents pending with Cedars-Sinai Medical Center, University of California, Los Angeles, California Institute of Technology and Avenzoar Pharmaceuticals.
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; AVEO; Basilea Pharmaceutical; Bayer; Clinical Congress Consultants; Elsevier; EMD Serono; Exelixis; HalioDx; Janssen Biotech; Natera; QED Therapeutics
Consulting or Advisory Role - Amgen; Astellas Pharma; Clinical Congress Consultants; Elsevier; Exelixis; QED Therapeutics
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera; Valar Labs
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Arsen Osipov
No Relationships to Disclose